1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Hypoactive Sexual Desire Disorder

In brief

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the treatment of HSDD (with or without decreased arousal) in premenopausal females.

Key facts

Study ID

NCT02333071

Run by

Palatin Technologies, Inc

People needed

723

Starts

2014-12-01

Expected to finish

2017-06-30

Last updated by the study team

2021-04-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Palatin Clinical Site 110 — Huntsville, Alabama, United States
• Palatin Clinical Site 106 — Mobile, Alabama, United States
• Palatin Clinical Site 149 — Scottsdale, Arizona, United States
• Palatin Clinical Site 157 — Tucson, Arizona, United States
• Palatin Clinical Site 166 — Little Rock, Arkansas, United States
• Palatin Clinical Site 102 — National City, California, United States
• Palatin Clinical Site 164 — Oceanside, California, United States
• Palatin Clinical Site 152 — Orange, California, United States
• Palatin Clinical Site 188 — Sacramento, California, United States
• Palatin Clinical Site 141 — San Diego, California, United States
• Palatin Clinical Site 187 — Walnut Creek, California, United States
• Palatin Clinical Site 160 — Centennial, Colorado, United States
• Palatin Clinical Site 185 — Colorado Springs, Colorado, United States
• Palatin Clinical Site 130 — Bradenton, Florida, United States
• Palatin Clinical Site 128 — Hollywood, Florida, United States
• Palatin Clinical Site 134 — Jacksonville, Florida, United States
• Palatin Clinical Site 108 — Melbourne, Florida, United States
• Palatin Clinical Site 105 — Orlando, Florida, United States
• Palatin Clinical Site 131 — South Miami, Florida, United States
• Palatin Clinical Site 144 — St. Petersburg, Florida, United States
• Palatin Clinical Site 101 — West Palm Beach, Florida, United States
• Palatin Clinical Site 116 — Decatur, Georgia, United States
• Palatin Clinical Site 142 — Savannah, Georgia, United States
• Palatin Clinical Site 171 — Meridian, Idaho, United States
• Palatin Clinical Site 121 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.